Assessing for Causes of Obesity
Interventions:
Screening for Comorbidities
Relative comparison of the efficacy of various strategies to promote weight loss
*Insurance coverage for these procedures is dependent on the patient's plan and should be consulted for insurance-specific coverage.
Recommended for patients with BMI ≥ 30 or ≥ 27with obesity-related comorbidity
FDA Approved medications for weight loss:
How to choose your med:
General Advice Regarding Medications:
Find out if your patient’s insurance company covers Anti-Obesity Medications (AOMs)
We recommend getting this information before completing a prior authorization to use time efficiently, as many insurance companies have clear exclusion policies for AOMs.
